MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $723,000 | -56.5% | 26,208 | -56.2% | 0.00% | -100.0% |
Q2 2019 | $1,662,000 | -86.4% | 59,821 | -83.8% | 0.00% | -78.6% |
Q1 2019 | $12,254,000 | +306250.0% | 369,091 | +310060.5% | 0.01% | – |
Q2 2018 | $4,000 | -99.9% | 119 | -99.9% | 0.00% | -100.0% |
Q1 2018 | $3,112,000 | +820.7% | 105,319 | +971.6% | 0.00% | – |
Q4 2017 | $338,000 | -85.3% | 9,828 | -86.9% | 0.00% | -100.0% |
Q2 2016 | $2,295,000 | +175.5% | 75,000 | +237.7% | 0.01% | +150.0% |
Q3 2015 | $833,000 | +250.0% | 22,207 | +217.2% | 0.00% | +100.0% |
Q2 2015 | $238,000 | – | 7,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |